ArticleAmerican journal of nuclear medicine and molecular imaging2018

Pre-treatment partial-volume-corrected TLG is the best predictor of overall survival in patients with relapsing/refractory non-hodgkin lymphoma following radioimmunotherapy.

Raheleh Taghvaei et al.PubMed ↗Full text ↗

No numbers read from the abstract.